Results 211 to 220 of about 42,113 (251)

Orthopaedic Management in Duchenne Muscular Dystrophy. [PDF]

open access: yesJ Pediatr Soc North Am
Balachandran U, Mustapich T, Ranade SC.
europepmc   +1 more source

Preventing Cardiomyopathy in Duchenne Muscular Dystrophy: Long-Term Follow-Up of Patients in the Randomised, Placebo-Controlled Drug-Trial of Perindopril and Bisoprolol. [PDF]

open access: yesEur J Neurol
Bourke JP   +10 more
europepmc   +1 more source

Failure to resolve inflammation contributes to juvenile onset cardiac damage in a mouse model of Duchenne muscular dystrophy. [PDF]

open access: yesCell Death Dis
Novak JS   +11 more
europepmc   +1 more source

Quantitative Muscle Magnetic Resonance Outcomes in Patients With Duchenne Muscular Dystrophy: An Exploratory Analysis From the EMBARK Randomized Clinical Trial.

open access: yesJAMA Neurol
Vandenborne K   +14 more
europepmc   +1 more source

The dystrophy of Duchenne

The Lancet, 2001
Duchenne muscular dystrophy While the eponym, Duchenne muscular dystrophy (DMD), is applied to the most common and most severe muscular dystrophy of childhood, Duchenne was not the first to describe the condition. 10 years before Duchenne reported his first case of Duchenne dystrophy, the London physician Meryon had described the condition.
Jiri Vajsar, Venita Jay
openaire   +3 more sources

Home - About - Disclaimer - Privacy